FL77-9

N/A

Report date: 2024/02/23 17:49:48
NME

Base Information

Drug NameFL77-9
Drug Alias NameFL77-9FL779
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApoptosis stimulantsDNA topoisomerase I inhibitors
TargetsDNA topoisomerase I
Therapy Area/IndicationsLymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCanget BioTekpharma LLC
China Registration ClassN/A

Develop Information

Active CompaniesCanget BioTekpharma LLC
Inactive CompaniesN/A
Active IndicationsLymphoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A